These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27678269)

  • 1. Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL.
    Deans ZC; Costa JL; Cree I; Dequeker E; Edsjö A; Henderson S; Hummel M; Ligtenberg MJ; Loddo M; Machado JC; Marchetti A; Marquis K; Mason J; Normanno N; Rouleau E; Schuuring E; Snelson KM; Thunnissen E; Tops B; Williams G; van Krieken H; Hall JA;
    Virchows Arch; 2017 Jan; 470(1):5-20. PubMed ID: 27678269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
    Deans ZC; Butler R; Cheetham M; Dequeker EMC; Fairley JA; Fenizia F; Hall JA; Keppens C; Normanno N; Schuuring E; Patton SJ
    Virchows Arch; 2019 Jun; 474(6):681-689. PubMed ID: 31028539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the Ion AmpliSeq Cancer Hotspot Panel in clinical molecular pathology laboratories for analysis of solid tumours: With emphasis on validation with relevant single molecular pathology tests and the Oncomine Focus Assay.
    Lee A; Lee SH; Jung CK; Park G; Lee KY; Choi HJ; Min KO; Kim TJ; Lee EJ; Lee YS
    Pathol Res Pract; 2018 May; 214(5):713-719. PubMed ID: 29615338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical validation of the 50 gene AmpliSeq Cancer Panel V2 for use on a next generation sequencing platform using formalin fixed, paraffin embedded and fine needle aspiration tumour specimens.
    Rathi V; Wright G; Constantin D; Chang S; Pham H; Jones K; Palios A; Mclachlan SA; Conron M; McKelvie P; Williams R
    Pathology; 2017 Jan; 49(1):75-82. PubMed ID: 27913044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive evaluation and validation of targeted next-generation sequencing performance in two clinical laboratories.
    Mendez P; Dang J; Kim JW; Lee S; Yoon JH; Kim T; Sailey CJ; Jablons DM; Kim IJ
    Int J Oncol; 2016 Jul; 49(1):235-42. PubMed ID: 27121194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.
    Peng R; Zhang R; Horan MP; Zhou L; Chai SY; Pillay N; Tay KH; Badrick T; Li J
    Oncologist; 2020 Mar; 25(3):218-228. PubMed ID: 32162803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Good Laboratory Standards for Clinical Next-Generation Sequencing Cancer Panel Tests.
    Kim J; Park WY; Kim NKD; Jang SJ; Chun SM; Sung CO; Choi J; Ko YH; Choi YL; Shim HS; Won JK;
    J Pathol Transl Med; 2017 May; 51(3):191-204. PubMed ID: 28535585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations for Next-Generation Sequencing Germline Variant Confirmation: A Joint Report of the Association for Molecular Pathology and National Society of Genetic Counselors.
    Crooks KR; Farwell Hagman KD; Mandelker D; Santani A; Schmidt RJ; Temple-Smolkin RL; Lincoln SE
    J Mol Diagn; 2023 Jul; 25(7):411-427. PubMed ID: 37207865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-Generation Sequencing Informatics: Challenges and Strategies for Implementation in a Clinical Environment.
    Roy S; LaFramboise WA; Nikiforov YE; Nikiforova MN; Routbort MJ; Pfeifer J; Nagarajan R; Carter AB; Pantanowitz L
    Arch Pathol Lab Med; 2016 Sep; 140(9):958-75. PubMed ID: 26901284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada.
    Spence T; Sukhai MA; Kamel-Reid S; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):353-360. PubMed ID: 31896933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Best practice guidelines for the use of next-generation sequencing applications in genome diagnostics: a national collaborative study of Dutch genome diagnostic laboratories.
    Weiss MM; Van der Zwaag B; Jongbloed JD; Vogel MJ; Brüggenwirth HT; Lekanne Deprez RH; Mook O; Ruivenkamp CA; van Slegtenhorst MA; van den Wijngaard A; Waisfisz Q; Nelen MR; van der Stoep N
    Hum Mutat; 2013 Oct; 34(10):1313-21. PubMed ID: 23776008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Canadian guideline on the use of next-generation sequencing in oncology.
    Yip S; Christofides A; Banerji S; Downes MR; Izevbaye I; Lo B; MacMillan A; McCuaig J; Stockley T; Yousef GM; Spatz A
    Curr Oncol; 2019 Apr; 26(2):e241-e254. PubMed ID: 31043833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.
    Zhong Q; Wagner U; Kurt H; Molinari F; Cathomas G; Komminoth P; Barman-Aksözen J; Schneider-Yin X; Rey JP; Vassella E; Rogel U; Diebold J; McKee T; Jochum W; Kashofer K; Hofman P; Zischka M; Moch H; Rechsteiner M; Wild PJ
    Pathol Res Pract; 2018 Jul; 214(7):957-963. PubMed ID: 29807778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours.
    Singh RR; Patel KP; Routbort MJ; Aldape K; Lu X; Manekia J; Abraham R; Reddy NG; Barkoh BA; Veliyathu J; Medeiros LJ; Luthra R
    Br J Cancer; 2014 Nov; 111(10):2014-23. PubMed ID: 25314059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-minimization analysis of sequential genetic testing versus targeted next-generation sequencing gene panels in patients with pheochromocytoma and paraganglioma.
    Pipitprapat W; Pattanaprateep O; Iemwimangsa N; Sensorn I; Panthan B; Jiaranai P; Chantratita W; Sorapipatcharoen K; Poomthavorn P; Mahachoklertwattana P; Sura T; Tunteeratum A; Srichan K; Sriphrapradang C
    Ann Med; 2021 Dec; 53(1):1243-1255. PubMed ID: 34309460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Data on NGS Diagnostics: a survey from the Italian Society of Pathology (SIAPeC) NGS Network.
    Marchetti A; Barbareschi M; Barberis M; Buglioni S; Buttitta F; Fassan M; Fontanini G; Marchiò C; Papotti M; Pruneri G; Scarpa A; Stanta G; Tallini G; Troncone G; Veronese SM; Truini M; Sapino A
    Pathologica; 2021 Aug; 113(4):262-271. PubMed ID: 34463674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. College of American Pathologists' laboratory standards for next-generation sequencing clinical tests.
    Aziz N; Zhao Q; Bry L; Driscoll DK; Funke B; Gibson JS; Grody WW; Hegde MR; Hoeltge GA; Leonard DG; Merker JD; Nagarajan R; Palicki LA; Robetorye RS; Schrijver I; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2015 Apr; 139(4):481-93. PubMed ID: 25152313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.
    Penault-Llorca F; Kerr KM; Garrido P; Thunnissen E; Dequeker E; Normanno N; Patton SJ; Fairley J; Kapp J; de Ridder D; Ryška A; Moch H
    Virchows Arch; 2022 Sep; 481(3):351-366. PubMed ID: 35857103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
    Sie D; Snijders PJ; Meijer GA; Doeleman MW; van Moorsel MI; van Essen HF; Eijk PP; Grünberg K; van Grieken NC; Thunnissen E; Verheul HM; Smit EF; Ylstra B; Heideman DA
    Cell Oncol (Dordr); 2014 Oct; 37(5):353-61. PubMed ID: 25209392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.